ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008

NCI Resumes Clinical Education Grants

March 18, 1983

Foundations: Lasker Awards honor Work In Nitric Oxide, HIB Vaccine

October 4, 1996

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013